Evidence map›Paper›PMID 42233876›Full record

ArticleEuropean journal of histochemistry : EJH2026

Elevated caspase 3 expression correlates with severe inflammation in Crohn's disease.

Nafie Sejdiu, Michael Naumann, Michael Vieth

Abstract read
In one paragraph

Article in European journal of histochemistry : EJH, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nafie SejdiuInstitute of Pathology, Klinikum Bayreuth; Institute for University Teaching and Research Medical Campus Upper Franconia, Friedrich-Alexander-Universität Erlangen-Nürnberg, Bayreuth.
Michael NaumannInstitute of Pathology, Klinikum Bayreuth; Institute of Experimental Internal Medicine, Otto von Guericke University, Magdeburg.ORCID 0000-0002-8060-2313
Michael ViethInstitute of Pathology, Klinikum Bayreuth; Institute of Pathology, Klinikum Bayreuth; Institute of Experimental Internal Medicine, Otto von Guericke University, Magdeburg; Bavarian Cancer Research Center, Bayreuth.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Caspase 3 is a key executioner of apoptotic cell death and contributes to intestinal epithelial homeodynamics. Apoptotic dysregulation has been implicated in Crohn's disease, yet data on caspase 3 expression across disease activity states remain limited. This study analyzed caspase 3 expression in intestinal biopsies from Crohn's disease patients. Paraffin-embedded biopsies from 289 individuals were examined, including active disease (mild and severe inflammation), upper gastrointestinal involvement, remission and non-inflamed tissue. Expression in epithelial and immune cells was assessed by immunohistochemistry and scored using the Remmele immunoreactive score (IRS). Caspase 3 expression levels in epithelial cells increased in cases of severe inflammation (p=0.012), and immune cells exhibited even more pronounced expression levels (p<0.001). These findings suggest that caspase 3 expression in epithelial and immune cells may help to distinguish between mild and severe inflammation.

Indexed as

Caspase 3Crohn DiseaseInflammationAdultApoptosisFemaleHumansImmunohistochemistryIntestinal MucosaMaleMiddle AgedCASP3 protein, humanCaspase 3Apoptotic cell deathgastrointestinalimmunohistochemistrylamina propria

Identifiers

PMID42233876
PMCPMC13270643

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.